Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seasonal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02155881
What this trial is testing

Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia

Who this might be right for
Seasonal Allergic Rhinitis
AstraZeneca 80
Large-scale testing (Phase 3)Study completedNCT00660517
What this trial is testing

Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Who this might be right for
Seasonal Allergic Rhinitis
Meda Pharmaceuticals 607
Large-scale testing (Phase 3)Study completedNCT01728285
What this trial is testing

Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis

Who this might be right for
Allergic RhinitisGrass Allergy
ALK-Abelló A/S 261
Not applicableStudy completedNCT06800885
What this trial is testing

Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 5,000
Post-approval studies (Phase 4)Study completedNCT00893906
What this trial is testing

Inactivated Influenza Vaccine Effectiveness in Tropical Africa

Who this might be right for
Influenza
PATH 10,000
Testing effectiveness (Phase 2)Study completedNCT00293904
What this trial is testing

Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy

Who this might be right for
Hypersensitivity
Cytos Biotechnology AG 36
Post-approval studies (Phase 4)Study completedNCT03004131
What this trial is testing

MP-AzeFlu Allergen Chamber - Onset of Action Study

Who this might be right for
Seasonal Allergic Rhinitis
MEDA Pharma GmbH & Co. KG 82
Testing effectiveness (Phase 2)Study completedNCT00807053
What this trial is testing

Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)

Who this might be right for
Rhinitis, Allergic, Seasonal
AstraZeneca 480
Large-scale testing (Phase 3)Study completedNCT05310084
What this trial is testing

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 1,134
Not applicableStudy completedNCT01699165
What this trial is testing

Efficacy and Safety of Nasal Filters on Seasonal Allergic Rhinitis (Hay Fever)

Who this might be right for
Rhinitis, Allergic, Seasonal
University of Aarhus 24
Testing effectiveness (Phase 2)Study completedNCT00443495
What this trial is testing

Phase I/IIa Study on Chitin Microparticles in Subjects Suffering From Allergic Rhinitis

Who this might be right for
Seasonal Allergic Rhinitis
CMP Therapeutics Ltd 24
Post-approval studies (Phase 4)Study completedNCT05970887
What this trial is testing

Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines

Who this might be right for
Immune ResponseSafety
Catholic Kwandong University 154
Large-scale testing (Phase 3)Study completedNCT01711736
What this trial is testing

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age

Who this might be right for
Influenza
GlaxoSmithKline 606
Testing effectiveness (Phase 2)Study completedNCT02236052
What this trial is testing

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population

Who this might be right for
Virus DiseasesRNA Virus InfectionsRespiratory Tract Diseases+1 more
Medicago 450
Not applicableStudy completedNCT01764152
What this trial is testing

Clinical Trial to Assess the Influenza Vaccination (FLUVAC 02)

Who this might be right for
Adult Hospitalized
Institut National de la Santé Et de la Recherche Médicale, France 450
Large-scale testing (Phase 3)Study completedNCT02154308
What this trial is testing

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Adults

Who this might be right for
Healthy
Il-Yang Pharm. Co., Ltd. 787
Post-approval studies (Phase 4)Study completedNCT03023176
What this trial is testing

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 5, 2013

Who this might be right for
Influenza
Stanford University 20
Not applicableUnknownNCT05521763
What this trial is testing

Influenza Vaccine Uptake Among Healthcare Workers

Who this might be right for
Influenza Vaccines
International Centre for Diarrhoeal Disease Research, Bangladesh 3,000
Not applicableLooking for participantsNCT06714149
What this trial is testing

Impacts of Nitrogen Deposition in the Natural Environment on Pollen Allergy in Belgium

Who this might be right for
Pollen Allergy
prof. dr. Rik Schrijvers 200
Testing effectiveness (Phase 2)Study completedNCT00584584
What this trial is testing

An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever

Who this might be right for
Allergic Rhinitis
Novartis 36
Next Page